Dr Reddy’s Laboratories is currently trading at Rs 1277.70, up by 30.15 points or 2.42% from its previous closing of Rs 1247.55 on the BSE.
The scrip opened at Rs 1255.05 and has touched a high and low of Rs 1287.90 and Rs 1255.05 respectively. So far 160774 shares were traded on the counter.
The BSE group ‘A’ stock of face value Rs 1 has touched a 52-week high of Rs 1420.20 on 21-Aug-2024 and a 52-week low of Rs 1025.90 on 07-Apr-2025.
Last one week high and low of the scrip stood at Rs 1287.90 and Rs 1232.00 respectively. The current market cap of the company is Rs 106651.21 crore.
The promoters holding in the company stood at 26.64%, while Institutions and Non-Institutions held 52.07% and 10.26% respectively.
Dr Reddy’s Laboratories has reported 2- fold jump in its net profit at Rs 2961.20 crore for the first quarter ended June 30, 2025 as compared to Rs 1417.20 crore for the same quarter in the previous year. Total income of the company increased by 35.46% at Rs 8207.80 crore for Q1FY26 as compared to Rs 6059.00 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 1.85% jump in net profit at Rs 1418.10 crore for Q1FY26 as compared to Rs 1392.40 crore for the same quarter in the previous year. Total income of the company increased by 12.41% at Rs 8862.40 crore for Q1FY26 as compared to Rs 7883.30 crore for the corresponding quarter previous year.
Bhupendra Singh Chundawat is a seasoned technology journalist with over 22 years of experience in the media industry. He specializes in covering the global technology landscape, with a deep focus on manufacturing trends and the geopolitical impact on tech companies. Currently serving as the Editor at Udaipur Kiran, his insights are shaped by decades of hands-on reporting and editorial leadership in the fast-evolving world of technology.
Dr Reddy’s Laboratories moves higher on reporting marginal rise in Q1 consolidated net profit
